This suggests that in cases of macular degeneration with active neovascularization, a capsule graft might require adjunctive measures (e.g., an anti-VEGF environment or edge sealing) to stop choroidal vessels from crossing over. This evidence concerns the gene VEGFA and macular degeneration.